85 related articles for article (PubMed ID: 7522162)
21. Use of dentritic cells pulsed with HLA-A2-restricted MAGE-A1 peptide to generate cytotoxic T lymphocytes against malignant glioma.
Shi H; Jiang X; Fu P; Zhou Y; Lu X
J Huazhong Univ Sci Technolog Med Sci; 2010 Oct; 30(5):678-82. PubMed ID: 21063856
[TBL] [Abstract][Full Text] [Related]
22. Molecular cancer vaccines: Tumor therapy using antigen-specific immunizations.
Schweighoffer T
Pathol Oncol Res; 1997 Sep; 3(3):164-76. PubMed ID: 18470726
[TBL] [Abstract][Full Text] [Related]
23. Expression of MAGE tumor-associated antigen in thyroid carcinomas.
Milkovic M; Sarcevic B; Glavan E
Endocr Pathol; 2006; 17(1):45-52. PubMed ID: 16760579
[TBL] [Abstract][Full Text] [Related]
24. A new MAGE-4 antigenic peptide recognized by cytolytic T lymphocytes on HLA-A24 carcinoma cells.
Ottaviani S; Colau D; van der Bruggen P; van der Bruggen P
Cancer Immunol Immunother; 2006 Jul; 55(7):867-72. PubMed ID: 16151806
[TBL] [Abstract][Full Text] [Related]
25. A MAGE-1 antigenic peptide recognized by human cytolytic T lymphocytes on HLA-A2 tumor cells.
Ottaviani S; Zhang Y; Boon T; van der Bruggen P
Cancer Immunol Immunother; 2005 Dec; 54(12):1214-20. PubMed ID: 16025263
[TBL] [Abstract][Full Text] [Related]
26. Identification of HLA-Cw6.02 and HLA-Cw7.01 allele-specific binding motifs by screening synthetic peptide libraries.
Dionne SO; Lake DF; Grimes WJ; Smith MH
Immunogenetics; 2004 Sep; 56(6):391-8. PubMed ID: 15309347
[TBL] [Abstract][Full Text] [Related]
27. A listing of human tumor antigens recognized by T cells: March 2004 update.
Novellino L; Castelli C; Parmiani G
Cancer Immunol Immunother; 2005 Mar; 54(3):187-207. PubMed ID: 15309328
[TBL] [Abstract][Full Text] [Related]
28. Immunopathogenic mechanisms in psoriasis.
Gudjonsson JE; Johnston A; Sigmundsdottir H; Valdimarsson H
Clin Exp Immunol; 2004 Jan; 135(1):1-8. PubMed ID: 14678257
[TBL] [Abstract][Full Text] [Related]
29. Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.
Jäger E; Gnjatic S; Nagata Y; Stockert E; Jäger D; Karbach J; Neumann A; Rieckenberg J; Chen YT; Ritter G; Hoffman E; Arand M; Old LJ; Knuth A
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12198-203. PubMed ID: 11027314
[TBL] [Abstract][Full Text] [Related]
30. Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.
Gnjatic S; Nagata Y; Jager E; Stockert E; Shankara S; Roberts BL; Mazzara GP; Lee SY; Dunbar PR; Dupont B; Cerundolo V; Ritter G; Chen YT; Knuth A; Old LJ
Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10917-22. PubMed ID: 11005863
[TBL] [Abstract][Full Text] [Related]
31. Expression of MAGE-1 and -3 genes and gene products in human hepatocellular carcinoma.
Kariyama K; Higashi T; Kobayashi Y; Nouso K; Nakatsukasa H; Yamano T; Ishizaki M; Kaneyoshi T; Toshikuni N; Ohnishi T; Fujiwara K; Nakayama E; Terracciano L; Spagnoli GC; Tsuji T
Br J Cancer; 1999 Nov; 81(6):1080-7. PubMed ID: 10576668
[TBL] [Abstract][Full Text] [Related]
32. Prospects for the therapeutic use of anticancer vaccines.
Chamberlain RS
Drugs; 1999 Mar; 57(3):309-25. PubMed ID: 10193685
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic T lymphocytes to an unmutated tumor rejection antigen P1A: normal development but restrained effector function in vivo.
Sarma S; Guo Y; Guilloux Y; Lee C; Bai XF; Liu Y
J Exp Med; 1999 Mar; 189(5):811-20. PubMed ID: 10049945
[TBL] [Abstract][Full Text] [Related]
34. Human tumor antigens recognized by T-cells.
Kawakami Y; Rosenberg SA
Immunol Res; 1997; 16(4):313-39. PubMed ID: 9439758
[TBL] [Abstract][Full Text] [Related]
35. Tumor antigens discovery: perspectives for cancer therapy.
Wang RF
Mol Med; 1997 Nov; 3(11):716-31. PubMed ID: 9407548
[TBL] [Abstract][Full Text] [Related]
36. Detection of MAGE-4 protein in the sera of patients with hepatitis-C virus-associated hepatocellular carcinoma and liver cirrhosis.
Tsuzurahara S; Sata M; Iwamoto O; Shichijo S; Kojiro M; Tanikawa K; Itoh K
Jpn J Cancer Res; 1997 Sep; 88(9):915-8. PubMed ID: 9369941
[TBL] [Abstract][Full Text] [Related]
37. A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma.
Mandruzzato S; Brasseur F; Andry G; Boon T; van der Bruggen P
J Exp Med; 1997 Aug; 186(5):785-93. PubMed ID: 9271594
[TBL] [Abstract][Full Text] [Related]
38. Expression of MAGE genes in ocular melanoma during progression from primary to metastatic disease.
Chen PW; Murray TG; Uno T; Salgaller ML; Reddy R; Ksander BR
Clin Exp Metastasis; 1997 Sep; 15(5):509-18. PubMed ID: 9247253
[TBL] [Abstract][Full Text] [Related]
39. HLA-C revisited. Ten years of change.
Falk CS; Schendel DJ
Immunol Res; 1997; 16(2):203-14. PubMed ID: 9212365
[TBL] [Abstract][Full Text] [Related]
40. Detection of MAGE-4 protein in sera of lung cancer patients.
Shichijo S; Hoshino T; Koufuji K; Hayashi A; Kawamoto M; Kikuchi M; Higuchi T; Ichiki M; Oizumi K; Itoh K
Jpn J Cancer Res; 1997 Apr; 88(4):414-9. PubMed ID: 9197535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
